Business Context and Reporting Period
This Form 8-K was filed by NU SKIN ENTERPRISES, INC. on September 10, 2024. The report addresses a corporate governance event regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the expansion of the Board of Directors:
- Board Composition: The Board size increased from eight to nine members.
- New Appointment: Mark A. Zorko was appointed as a director.
- Committee Assignments: Mr. Zorko was appointed to the Audit Committee and the Nominating and Corporate Governance Committee.
Guidance, Outlook, and Management Commentary
Compensation Arrangements: Mr. Zorko's compensation will follow the Company's non-employee director program. Due to joining approximately three months after the 2024 Annual Meeting, his cash retainers and annual equity award for the current term are pro-rated to 75% of the standard amounts disclosed in the 2024 Proxy Statement.
Related Transactions: The Company confirmed there are no reportable related-person transactions involving Mr. Zorko and no special arrangements regarding his selection.
Indemnification: It is expected that Mr. Zorko will enter into an indemnification agreement substantially identical to those held by other directors and executive officers.
Investor Verification Checklist
- Verify the pro-rated compensation details for Mr. Zorko in the 2024 Proxy Statement.
- Confirm the updated composition of the Audit Committee and Nominating and Corporate Governance Committee.
- Review the standard indemnification agreement form used by the Company for directors.